Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|April 3, 2002

Varian releases planning tool

Radiotherapy giant Varian Medical Systems has begun marketing its latest treatment planning software for brachytherapy.

Radiotherapy giant Varian Medical Systems has begun marketing its latest treatment planning software for brachytherapy. VariSeed 7.0 helps physicians accurately deliver precise doses by providing access to real-time images generated during the implantation of radioactive seeds. The use of these seeds to treat prostate cancer has become increasingly common, producing results comparable to radical prostatectomy but with a lower risk of side effects such as impotence and incontinence. With VariSeed 7.0, radiation oncologists can generate a treatment plan, use it to implant the seeds, and see how the radiation dose will develop within the patient's anatomy while the patient is still in the operating room. This allows for fine-tuning and more precise adjustments on the spot, according to the company. VariSeed 7.0 also introduces the ability to superimpose different kinds of diagnostic images; SPECT, for example, can demonstrate the extent of disease, while CT and ultrasound show anatomy and positioning.

Related to this article

Teleradiology With More Pay and Less Pressure
Expert Radiology is a **radiologist-run teleradiology practice with 10 years of experience**, hiring teleradiologists earning **$500–$900/hr with per-dictation pay**. Work from anywhere with true flexibility, **no shifts, no call, and no weekends**. Our case mix is **predominantly outpatient and noncontrast**, with approximately **75% MRI**, plus X-ray and CT. We cover **malpractice with tail**, handle all medical licensing, and ship you a **$10K reading station with six vertical 4K monitors**. Minimum commitment is an **average of 400 cases per month**. **Book a call with Brandi Escapule, Principal, Physician Services.**
Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.